CARA THERAPEUTICS INC (CARA) Stock Balance Sheet
NASDAQ:CARA - Nasdaq - US1407552082 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.90M | 51.77M | 63.70M | 13.50M | 31.70M | |||
| Marketable Securities | 0.00 | 48.98M | 81.70M | 153.60M | 149.20M | |||
| Receivables | 4.50M | 4.02M | 4.50M | 1.20M | 2.10M | |||
| Inventories | 900.00K | 2.82M | 2.40M | 2.60M | N/A | |||
| Other Current Assets | 529.00K | 8.56M | 16.70M | 2.50M | 12.10M | |||
| Total Current Assets | 43.83M | 116.16M | 168.90M | 173.30M | 195.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 8.19M | 2.00M | 3.60M | 5.10M | |||
| Investments And Advances | N/A | 0.00 | 11.40M | 69.80M | 70.60M | |||
| Other Non-Current Assets | 0.00 | 1.50M | 0.00 | 400.00K | 400.00K | |||
| Total Non-Current Assets | 0.00 | 9.69M | 13.30M | 73.80M | 76.10M | |||
| TOTAL ASSETS | 43.83M | 125.84M | 182.20M | 247.10M | 271.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.54M | 14.01M | 13.90M | 12.00M | 13.60M | |||
| Accounts Payable | 1.43M | 11.58M | 9.60M | 5.60M | 4.90M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 3.97M | 25.59M | 23.50M | 17.60M | 18.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 44.45M | 43.17M | 0.00 | 1.90M | 3.70M | |||
| Total Non-Current Liabilities | 44.45M | 43.17M | 0.00 | 1.90M | 3.70M | |||
| TOTAL LIABILITIES | 48.42M | 68.76M | 23.50M | 19.50M | 22.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -755.61M | -684.75M | -566.20M | -480.80M | -392.30M | |||
| Additional Paid In Capital | 751.01M | 742.04M | 726.60M | 708.60M | 641.20M | |||
| Common Shares | 5.00K | 54.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | -260.00K | -1.70M | -400.00K | 100.00K | |||
| Shares Outstanding | 4.57M | 4.54M | 53.80M | 53.50M | 49.90M | |||
| Tangible Book Value per Share | -1.00 | 12.57 | 2.95 | 4.25 | 4.99 | |||
| Total Shareholders' Equity | -4.59M | 57.09M | 158.80M | 227.50M | 249.00M | |||
| TOTAL LIABILITIES AND EQUITY | 43.83M | 125.84M | 182.20M | 247.10M | 271.20M | |||
| Statistics | ||||||||
| Current Ratio | 11.03 | 4.54 | 7.19 | 9.85 | 10.55 | |||
| Return On Assets (ROA) | -161.70% | -94.17% | -46.93% | -35.77% | 3.10% | |||
| Return On Equity (ROE) | N/A | -207.61% | -53.84% | -38.86% | 3.37% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 1.69% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 5.94% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 5.94% | |||
All data in USD , ROIC based on taxRate of 0.21